J Korean Ophthalmol Soc.  2000 Feb;41(2):307-313.

Long Term Surgical Efficacy of Endonasal Dacryo cys torhinostomy

Affiliations
  • 1Department of Ophthalmology, Yeungnam University College of Medicine.

Abstract

Primary success rate of endonasal dacryocystorhinostomy has been reported lower than that of conventional cedure. Gradual stenosis of mucosal ostium would progress until 6 to 10 months following operation and a longterm follow-up should be necessary. Endonasal dacryocystorhinostomy was performed in 100 patients[118 eyes]between July 1993 and March 1998 at the Department of Ophthalmology, Yeungnam University College of Medicine. After the follow-up period of 1 to 4 years[average 16.2 months], longterm success rate, postoperative omplications, and factors to affect success rate were studied. The success rate of primary operation was 89.83%, and the success rate after secondary revision of the ostium was up to 99.15%. Granulation tissue formation was the most common postoperative complication, and other complications included protrusion of silicone tube, membranous obstruction, partial obstruction of common canaliculus, canaliculitis and prolapse of orbital fat. Factors to obtain good success rate were careful and acurate surgical technique to achieve large mucosal ostium, postoperative management, antibiotics and steroid medication, etc. Long-term surgical efficacy of endonasal dacryocystorhinostomy was similar to skin approach and secondary success rate following revision was very satisfactory.

Keyword

Endonasal DCR; Long term success rate

MeSH Terms

Anti-Bacterial Agents
Bezafibrate
Constriction, Pathologic
Dacryocystorhinostomy
Follow-Up Studies
Granulation Tissue
Ophthalmology
Orbit
Postoperative Complications
Prolapse
Silicones
Skin
Canaliculitis
Anti-Bacterial Agents
Bezafibrate
Silicones
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr